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SUMMARY
Epidemiological data regarding group A streptococcal (GAS) infections in South East Asia
are scarce with no information from Laos. We characterized emm types, emm clusters and the
antibiotic resistance proﬁle of 124 GAS isolates recovered in Laos during 2004–2013. Most strains
were recovered from skin and invasive infections (76% and 19%, respectively). Thirty-four emm
types were identiﬁed as belonging to 12 emm clusters and no novel emm types were identiﬁed. No
signiﬁcant differences were observed in the distribution of emm types or emm clusters according to
age or site of recovery (skin or invasive infections). There was moderate strain diversity in this
country but considerable differences in emm-type distribution between Laos, Thailand and
Cambodia. Vaccine coverage was high for the J8 vaccine candidate. The theoretical coverage for
the 30-valent vaccine candidate needs further investigation. Antibiotic resistance was moderate to
erythromycin and chloramphenicol (8% and 7%, respectively) and low to oﬂoxacin (<1%).
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Group A streptococci (Streptococcus pyogenes; GAS)
cause signiﬁcant morbidity and mortality globally
with most of the disease burden occurring in low-
and middle-income settings. With no effective control
strategies available, a GAS vaccine is urgently needed.
The most advanced vaccine candidates use the surface
M protein as antigen. Two vaccine candidates have
entered phase 1 clinical trials over the past decade
with a further two vaccines planned for trials in
2015 [1]. The 30-valent type-speciﬁc vaccine candidate
includes peptides from a selection of M proteins asso-
ciated with disease burden in both high- and low-
income settings but questions have been raised regard-
ing coverage in low-income settings where a high di-
versity of circulating emm types has been observed
[2, 3]. The J8 vaccine is based on a conserved region
of the M protein (J8) and aims to provide broad pro-
tection across many strains. However, no fewer than
68 allelic variants have been described for J8 and the
relationship between allelic diversity and vaccine
efﬁcacy has not yet been systematically characterized
[1]. Importantly, limited epidemiological data regard-
ing circulating emm types and J8 variants are available
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from a number of key regions of the world making
vaccine-coverage estimates imprecise, especially from
South East Asia with only one study originating
from a low-income country (Cambodia) [2–4].
The Lao People’s Democratic Republic (Laos) is a
low- to middle-income country with a population of
∼6·9 million people which, despite rapid economic
growth, is still one of the poorest in South East Asia
(http://data.worldbank.org/country/lao-pdr). It also
has some of the worst health indicators in the region,
with an average life expectancy of 65 years for males
and 68 years for females, and an infant mortality
rate of 54/1000 live births in 2013 (http://apps.who.
int/gho/data/view.main.CM1320R?lang=en). In add-
ition, very few diagnostic laboratories undertake bac-
terial culture, therefore data on the epidemiology and
antimicrobial susceptibility of bacterial pathogens
within Laos are very scarce.
The Microbiology Laboratory of Mahosot Hospital,
the largest hospital in the capital, Vientiane, has con-
ducted culture-based diagnosis of bacterial infections
and storage of signiﬁcant pathogens since 2000. We
analysed these databases to identify GAS isolates
recovered during a 10-year period (2004–2013). We
extracted clinical details and demographic information
of patients with GAS infection, including geographical
coordinates of the addresses of the patients. Invasive
disease was deﬁned as the isolation of GAS from
blood in a patient with a clinical infection. Skin infec-
tion, acute otitis media, and pharyngitis was deﬁned
by the presence of clinical symptoms associated with
the isolation of GAS from the relevant site.
Identiﬁcation of GAS was based on colony morph-
ology, β-haemolysis on 5% goat blood agar, negative
catalase reaction, and detection of Lanceﬁeld Group
A antigen by latex agglutination (Streptococcal
Grouping kit, Oxoid, UK). Antibiotic susceptibility
to four antibiotics (penicillin, erythromycin, oﬂoxacin,
chloramphenicol) was determined by the CLSI disk
diffusion method and isolates were frozen at −80 °C
prior to shipment to Melbourne for further testing.
The isolates were re-conﬁrmed as GAS as above and
were then emm-typed according to the US Centers
for Disease Control and Prevention protocol with
minor modiﬁcations; primers MF2 and MR1 were
used when primers 1 and 2 were not successful, as
described previously [5]. In addition to emm-typing,
we also classiﬁed isolates into emm clusters. This typ-
ing system classiﬁes the many GAS emm types into 48
discrete emm clusters containing closely related M
proteins that share binding and structural properties
[6–8]. emm clusters can be directly deduced by the
emm-typing result and predict the J8 vaccine antigen
content [6]. Coverage by the 30-valent vaccine was
estimated using the latest cross-opsonization data
[6, 9, 10]. We used Simpson’s Reciprocal Index
(SRI) to assess strain diversity [3]. Regional molecular
epidemiology was assessed by comparison of the data
with a similar dataset from Thailand [11] and
Cambodia [4].
The Oxford Tropical Research Ethics Committee
and National Ethics Committee for Health Research,
Government of Laos approved this study.
We characterized 124 GAS isolates. Median patient
age was 35 years (interquartile range 7–56, range 0–
92; data available for 121/124 patients) and 31·4% of
the patients were aged <15 years at presentation.
Most of the patients were diagnosed with a skin infec-
tion (94/124, 76%) followed by invasive infection (24/
124, 19%). There was no clinical information available
for four patients. We identiﬁed 34 emm types as
belonging to 12 emm clusters and no novel emm
types were identiﬁed (Table 1). No signiﬁcant differ-
ences were observed in the distribution of emm types
or emm clusters according to age or site of recovery
(skin or invasive infections). Four isolates were non-
typable. While there were 34 different emm types
observed among 124 GAS isolates in this study, the
strain diversity as measured by the SRI (that takes
into account both richness and evenness), was 13·2
[95% conﬁdence interval (CI) 9·6–21·5]. This indicates
a relatively moderate strain diversity in comparison to
data from children in Cambodia (SRI = 28·5) and
Table 1. emm clusters and emm types of the GAS
isolates characterized in the study
emm cluster Isolates (n) emm types (n)
E3 47 25 (6), 44 (28), 49 (2), 58 (4),
79 (3), 82 (4)
E4 21 8 (1), 22 (5), 73 (2), 77 (2), 89
(1), 102 (1), 109 (8), 114 (1)
E2 15 76 (4), 104 (5), 106 (4), 110 (2)
E6 12 11 (1), 63 (2), 75 (6), 81 (3)
D4 8 33 (2), 70 (1), 101 (1), 230 (4)
M95 4 95 (4)
Non-typable 4 Non-typable (4)
E1 3 4 (1), 165 (2)
M74 3 74 (3)
M105 3 105 (3)
M185 2 185 (2)
A-C3 1 1 (1)
D2 1 100 (1)
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other other low-income countries [2, 4]. Geographical
coordinates of the patient’s home were available for
117/124 patients included in this study and showed
that 96% (112/117) of patients’ homes were within
∼100 km radius of Vientiane, the main catchment
area of Mahosot Hospital. This relatively small geo-
graphical area may partially account for the relatively
low diversity of strains observed.
No isolate was resistant to penicillin; however, one
isolate was resistant to oﬂoxacin (another was inter-
mediate), nine (7%) were resistant to chloramphenicol
(three intermediate) and 10 (8%) were resistant to
erythromycin. These chloramphenicol- and erythro-
mycin-resistant isolates belonged to seven and six dif-
ferent emm types, respectively. Of note, seven of the 10
erythromycin-resistant isolates were also resistant
to chloramphenicol. These data represent the ﬁrst in-
formation about GAS antibiotic resistance in South
East Asia. Data from East Asia indicate rates of ery-
thromycin resistance ranging from 8% to 14·6% in
Taiwan during the period 2010–2011 [12, 13], reaching
as high as >95% in China [14].
Sixty-one (49%) isolates belonged to emm types
included in the 30-valent vaccine candidate. Thirty-
eight (31%) isolates were emm types that have been
shown to be cross-opsonized in a rabbit model and
therefore have the potential to be covered by the
30-valent vaccine. Taking into account this cross-
opsonization effect, the theoretical coverage could be
80% (95% CI 73–87), but may be even higher since
19% of the isolates belonged to eight emm types that
had not yet been tested for cross-opsonization. These
eight emm types should be investigated for potential
cross-opsonization in order to better assess the theor-
etical coverage of the 30-valent vaccine in Laos. In
terms of theoretical coverage of the J8 vaccine candi-
date, 19 (15%) and 101 (82%) of the isolates were pre-
dicted to contain the J8 and J8·1 allele, respectively.
Therefore, J8 vaccine coverage could be expected to
be 97% (95% CI 94–100).
We compared these data to previous data from
Thailand and Cambodia. The Thailand dataset
comprises 106 GAS isolates from skin and throat
collected between 1985 and 2004, including those
from patients with rheumatic heart disease [11].
The Cambodian dataset comprises 150 GAS iso-
lates recovered from skin, throat and invasive infec-
tions in children collected between 2007 and 2012
[4]. The emm-type distribution between these three
countries shows that nearly half of the
Cambodian isolates belong to an emm type which
has not been recovered in the two other countries
(Fig. 1). By contrast, only 10 and 12% of the
strains isolated in Thailand and Laos,
respectively, belonged to an emm type not recov-
ered in the other two countries. The emm cluster
distribution shows that 86–97% of the strains be-
long to an emm cluster present in all three countries
Fig. 1. Comparison of the GAS isolates recovered from 3 South East Asian countries. Distribution of emm types and
emm clusters among GAS infections recovered from three Southeast Asian countries. The number of isolates (%)
associated with infections and belonging to speciﬁc and common (a) emm types and (b) emm clusters is shown for each
country.
1772 S. Rattanavong and others
(Fig. 1). Moreover, the distribution also shows that
the apparently distinct epidemiology of GAS in
Cambodia does not correlate with the presence of
speciﬁc emm clusters.
The most important limitation of our study is its
retrospective nature. In future, prospective and com-
prehensive GAS infection surveillance in Laos will
be highly desirable. Other limitations of our study
are the relative absence of pharyngeal isolates from
the collection and the restricted geographical sam-
pling area. Finally, caution should be exercised
when comparing the Lao, Thai and Cambodian
datasets given the methodological differences in
sampling and study periods. Notably, a potential
confounding factor for the differences in strain dis-
tribution is that the Cambodian isolates were all
from children. Better prospective data obtained
using similar methodologies in terms of study per-
iod, inclusion criteria and targeted population
should be obtained before ﬁrm conclusions can be
drawn.
Overall, these data indicate a relatively low diver-
sity of circulating GAS strains in the central region
from Laos, a high coverage of the J8 vaccine candi-
date and the need for complementary studies to assess
the potential coverage of the 30-valent vaccine candi-
date. These results also conﬁrm the importance of epi-
demiological studies at a local and regional level to
inform vaccine development.
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